CA2328950A1 - Piperidinopyrimidine derivatives for topical application - Google Patents
Piperidinopyrimidine derivatives for topical application Download PDFInfo
- Publication number
- CA2328950A1 CA2328950A1 CA002328950A CA2328950A CA2328950A1 CA 2328950 A1 CA2328950 A1 CA 2328950A1 CA 002328950 A CA002328950 A CA 002328950A CA 2328950 A CA2328950 A CA 2328950A CA 2328950 A1 CA2328950 A1 CA 2328950A1
- Authority
- CA
- Canada
- Prior art keywords
- weight
- piperidinopyrimidine
- topical application
- solvent
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Abstract
A pharmaceutical composition for topical administration, including, as the pharmaceutically active component, at least 5 % by weight, based on the total weight of the composition of a piperidinopyrimidine derivative or a pharmaceutically acceptable salt thereof; an acid in an amount to completely solubilise the piperidinopyrimidine derivative or a pharmaceutically acceptable salt thereof; a solvent composition including at least two of water, a lower alcohol and a co-solvent selected from one or more of the group consisting of aromatic and polyhydric alcohols; wherein when the co-solvent includes propylene glycol, it is present in an amount of less than approximately 10 %
by weight.
by weight.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP3107A AUPP310798A0 (en) | 1998-04-22 | 1998-04-22 | Vehicle system for a composition comprising a piperidinopyrimidine derivative |
AUPP3107 | 1998-04-22 | ||
PCT/AU1999/000294 WO1999053923A1 (en) | 1998-04-22 | 1999-04-20 | Pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2328950A1 true CA2328950A1 (en) | 1999-10-28 |
CA2328950C CA2328950C (en) | 2008-07-29 |
Family
ID=3807366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002328950A Expired - Lifetime CA2328950C (en) | 1998-04-22 | 1999-04-20 | Piperidinopyrimidine derivatives for topical application |
Country Status (13)
Country | Link |
---|---|
US (2) | US6946120B2 (en) |
EP (2) | EP1073439B1 (en) |
JP (3) | JP3710380B2 (en) |
AT (1) | ATE331517T1 (en) |
AU (1) | AUPP310798A0 (en) |
BR (1) | BR9909796B1 (en) |
CA (1) | CA2328950C (en) |
CY (1) | CY1120513T1 (en) |
DE (1) | DE69932158T2 (en) |
DK (2) | DK1695708T3 (en) |
ES (2) | ES2268856T3 (en) |
PT (2) | PT1695708T (en) |
WO (1) | WO1999053923A1 (en) |
Families Citing this family (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9504265D0 (en) | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
AUPO983897A0 (en) | 1997-10-17 | 1997-11-06 | Soltec Research Pty Ltd | Topical antifungal composition |
AUPP310798A0 (en) * | 1998-04-22 | 1998-05-14 | Soltec Research Pty Ltd | Vehicle system for a composition comprising a piperidinopyrimidine derivative |
JPH11349451A (en) * | 1998-06-08 | 1999-12-21 | Taisho Pharmaceut Co Ltd | Hair grower |
US8263580B2 (en) | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
US6342496B1 (en) * | 1999-03-01 | 2002-01-29 | Sepracor Inc. | Bupropion metabolites and methods of use |
EP1269972B1 (en) * | 2000-04-07 | 2005-10-19 | Taisho Pharmaceutical Co., Ltd | Hair growth stimulant compositions with sustained action |
NZ521830A (en) * | 2000-04-07 | 2004-07-30 | Taisho Pharmaceutical Co Ltd | Hair growth stimulant compositions |
JP4892786B2 (en) * | 2000-04-07 | 2012-03-07 | 大正製薬株式会社 | Sustainable hair growth preparation |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
US7442369B1 (en) * | 2000-08-09 | 2008-10-28 | Mcneil Ab | Compositions of minoxidil |
AUPR048600A0 (en) * | 2000-10-02 | 2000-10-26 | Soltec Research Pty Ltd | Pharmaceutical vehicle |
JP4189223B2 (en) * | 2001-05-15 | 2008-12-03 | 大正製薬株式会社 | Minoxidil combination liquid composition |
SE0104421D0 (en) * | 2001-12-21 | 2001-12-21 | Ponsus Pharma Ab | New composition |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
EP1556009B2 (en) | 2002-10-25 | 2021-07-21 | Foamix Pharmaceuticals Ltd. | Cosmetic and pharmaceutical foam |
EP1592420B1 (en) | 2003-01-24 | 2014-01-01 | Stiefel Research Australia Pty Ltd | Clindamycin phosphate foam |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US7186416B2 (en) | 2003-05-28 | 2007-03-06 | Stiefel Laboratories, Inc. | Foamable pharmaceutical compositions and methods for treating a disorder |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
AU2004275900B2 (en) | 2003-09-29 | 2010-04-29 | Deb Ip Limited | High alcohol content gel-like and foaming compositions |
GB0323908D0 (en) * | 2003-10-11 | 2003-11-12 | Nupharm Lab Ltd | Pharmaceutical foam formulation |
AU2003299882A1 (en) * | 2003-12-22 | 2005-08-03 | Regrowth, Llc | Topical solutions comprising high concentrations of piperidinopyrimidine derivatives and methods of use thereof |
US20050163811A1 (en) * | 2004-01-23 | 2005-07-28 | Richard Lee | Topical solutions comprising high concentrations of piperidinopyrimidine derivatives and methods of use thereof |
US20060034779A1 (en) * | 2004-08-02 | 2006-02-16 | Agis Industries (1983) Ltd. | Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same |
US20060057075A1 (en) * | 2004-08-02 | 2006-03-16 | Moshe Arkin | Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof |
DE102004062775A1 (en) | 2004-12-21 | 2006-06-29 | Stockhausen Gmbh | Alcoholic pump foam |
US8263098B2 (en) | 2005-03-07 | 2012-09-11 | Deb Worldwide Healthcare Inc. | High alcohol content foaming compositions with silicone-based surfactants |
CA2610662A1 (en) | 2005-05-09 | 2007-05-18 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
PL1917072T3 (en) | 2005-06-01 | 2014-01-31 | Glaxosmithkline Ip Dev Ltd | Vitamin formulation |
US8147815B2 (en) * | 2005-12-16 | 2012-04-03 | Celmatrix Corporation | Topical administration carrier composition and therapeutic formulations comprising same |
EP2206494B1 (en) | 2006-03-31 | 2015-12-02 | Stiefel Research Australia Pty Ltd | Foamable suspension gel |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
KR100893469B1 (en) * | 2006-12-22 | 2009-04-17 | 씨제이제일제당 (주) | Compositions containing minoxidil for the hair generation which have an improved skin permeation |
US8580860B2 (en) * | 2007-02-23 | 2013-11-12 | Gojo Industries, Inc. | Foamable alcoholic composition |
US8021649B2 (en) * | 2007-02-22 | 2011-09-20 | Cronk Peter J | Continuous spray scalp therapy and dispensing systems for same |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
CA2712120A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
JP5420946B2 (en) | 2009-03-23 | 2014-02-19 | 富士フイルム株式会社 | Minoxidil aqueous composition containing bile acids |
JP2010222317A (en) * | 2009-03-25 | 2010-10-07 | Shiseido Co Ltd | Oil-in-water type emulsified cosmetic |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9364485B2 (en) | 2009-08-31 | 2016-06-14 | Dr. Reddy's Laboratories Ltd. | Topical formulations comprising a steroid |
US8871184B2 (en) | 2009-10-02 | 2014-10-28 | Foamix Ltd. | Topical tetracycline compositions |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US20110189114A1 (en) * | 2010-01-29 | 2011-08-04 | Nyangenya Maniga | minoxidil composition and non-aerosol, non-spray foam method of delivery therefor |
US9271917B2 (en) | 2010-01-29 | 2016-03-01 | Nyangenya Maniga | Method and apparatus for delivery of a measured dosage of a non-aerosol, non-spray foam composition of minoxidil |
WO2012040342A2 (en) * | 2010-09-21 | 2012-03-29 | Conrex Pharmaceutical Corporation | Restoration of hair |
BR112013014021A8 (en) | 2010-12-06 | 2017-10-03 | Follica Inc | METHODS FOR TREATMENT OF BALDNESS AND PROMOTION OF HAIR GROWTH |
US9717741B2 (en) | 2012-10-11 | 2017-08-01 | Anaplasi Pharmaceuticals Llc | Method and compositions for treating psoriasis |
JP6059352B2 (en) | 2012-10-11 | 2017-01-11 | アナプラシ ファーマシューティカルズ エルエルシー | Methods and compositions for treating psoriasis |
WO2014122436A1 (en) | 2013-02-07 | 2014-08-14 | Cipla House | Topical pharmaceutical compositions comprising minoxidil |
US8642097B1 (en) | 2013-03-19 | 2014-02-04 | Nyangenya Maniga | Natural product energy drink and method of use thereof |
WO2014184173A1 (en) | 2013-05-14 | 2014-11-20 | Montero Gida Sanayi Ve Ticaret A.S. | Hair care formulations |
US20160184431A1 (en) | 2014-03-11 | 2016-06-30 | Promius Pharma Llc | Topical compositions comprising a corticosteroid |
US9474699B2 (en) | 2014-03-31 | 2016-10-25 | Johnson & Johnson Consumer Inc. | Compostions and methods for enhancing the topical application of a basic benefit agent |
US9468606B2 (en) | 2014-03-31 | 2016-10-18 | Johnson & Johnson Consumer Inc. | Compostions and methods for enhancing the topical application of an acidic benefit agent |
CN106456467A (en) | 2014-06-16 | 2017-02-22 | 强生消费者公司 | Compositions and methods for enhancing topical application of color cosmetic |
US20150359742A1 (en) | 2014-06-17 | 2015-12-17 | Johnson & Johnson Consumer Inc. | Compositions and methods for enhancing the topical application of a benefit agent including powder to liquid particles and a second powder |
US9675537B2 (en) * | 2014-06-30 | 2017-06-13 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
JP7072346B2 (en) * | 2015-03-27 | 2022-05-20 | 大正製薬株式会社 | Lotion |
WO2016159916A1 (en) * | 2015-03-31 | 2016-10-06 | Ogi̇g Sağlik Ürünleri̇ Ve Hi̇zmetleri̇ Sanayi̇ Ti̇caret Li̇mi̇ted Şi̇rketi̇ | A foamy pharmaceutical formulation used in dermatological diseases |
WO2016186896A1 (en) * | 2015-05-18 | 2016-11-24 | Thrower Angelo Perry | Hair regrowth treatment and growth stimulant |
US11185672B2 (en) | 2015-09-27 | 2021-11-30 | Follica, Inc. | Needling device and drug applicator |
ES2809704T3 (en) | 2015-10-06 | 2021-03-05 | Assos Ilac Kimya Gida Ueruenleri Ueretim Ve Tic A S | Topical composition of minoxidil |
US11666520B2 (en) * | 2015-12-28 | 2023-06-06 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
CN105434352A (en) * | 2015-12-31 | 2016-03-30 | 浙江万晟药业有限公司 | Minoxidil foaming agent as well as preparation method and application thereof |
JP2018048104A (en) * | 2016-01-22 | 2018-03-29 | 大正製薬株式会社 | Composition for external use |
JP2018048105A (en) * | 2016-01-22 | 2018-03-29 | 大正製薬株式会社 | Composition for external use |
JP6848565B2 (en) * | 2016-03-30 | 2021-03-24 | 大正製薬株式会社 | Aerosol agent |
MX2020012139A (en) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Compositions and methods for treating rosacea and acne. |
US10736905B1 (en) | 2016-09-09 | 2020-08-11 | Shahin Fatholahi | Nefopam dosage forms and methods of treatment |
JP7366515B2 (en) * | 2016-09-15 | 2023-10-23 | 大正製薬株式会社 | External composition |
US9962444B2 (en) | 2016-09-27 | 2018-05-08 | Shane Malek | Pharmacokinetically extended action topical hair growth formulation, and administration method |
US10702495B2 (en) | 2017-02-20 | 2020-07-07 | Nexien Biopharma, Inc. | Method and compositions for treating dystrophies and myotonia |
JP6990992B2 (en) | 2017-05-25 | 2022-01-12 | フクダ電子株式会社 | Biological signal recording device and its control method |
US11446311B2 (en) | 2017-09-08 | 2022-09-20 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
US10736874B1 (en) | 2017-09-08 | 2020-08-11 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
KR20210027271A (en) | 2018-05-30 | 2021-03-10 | 폴리카 인코포레이티드 | How to promote hair growth |
JP2019210268A (en) * | 2018-05-30 | 2019-12-12 | ダイヤ製薬株式会社 | External preparation and method for producing external preparation |
EP3750528A1 (en) | 2019-06-11 | 2020-12-16 | Nexien Biopharma, Inc. | Compositions for treating dystrophies and myotonia |
CN114025768B (en) | 2019-06-28 | 2023-12-22 | 古鲁生物制药有限公司 | Medicine for promoting hair growth |
WO2021026084A1 (en) | 2019-08-07 | 2021-02-11 | Aneira Pharma, Inc. | Compositions for the treatment of hair loss |
BR102021003531A2 (en) * | 2021-02-24 | 2022-08-30 | Eurofarma Laboratorios S.A. | FOAMBLE TOPICAL PHARMACEUTICAL COMPOSITION |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US515836A (en) * | 1894-03-06 | Basin-clamp | ||
US4139619A (en) * | 1976-05-24 | 1979-02-13 | The Upjohn Company | 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth |
US4596812A (en) * | 1976-05-24 | 1986-06-24 | The Upjohn Company | Methods and solutions for treating male pattern alopecia |
IT1066697B (en) * | 1976-11-08 | 1985-03-12 | Manetti & Roberts Italo Brit | ACTIVATOR FOR COSMETIC COMPOSITIONS AND COSMETIC COMPOSITIONS THAT CONTAIN IT |
US5183817A (en) * | 1981-02-17 | 1993-02-02 | Bazzano Gail S | Combinations of retinoids and minoxidil-type compounds for hair growth |
EP0093770B1 (en) * | 1981-11-09 | 1991-06-19 | BAZZANO, Gail S | The use of retinoids and minoxidil (2,4-diamino-6-piperidino-pyrimidine-3-oxide) to increase the rate of growth of human scalp hair and to treat certain types of alopecias |
EP0160051B1 (en) | 1983-10-24 | 1992-01-08 | Lockley Services Pty. Ltd. | Foamable biocide composition |
WO1986000196A1 (en) | 1984-06-21 | 1986-01-16 | Soltec Research Pty. Ltd. | Aerosol product |
JPS61197161A (en) | 1985-02-25 | 1986-09-01 | Amada Co Ltd | Dressing device |
IT1201436B (en) * | 1985-07-19 | 1989-02-02 | Vincenzo Zappia | TOPICAL SLOW RELEASE FORMULATIONS |
EP0249397B1 (en) * | 1986-06-13 | 1992-08-12 | The Procter & Gamble Company | Improved penetrating topical pharmaceutical compositions |
US5041439A (en) * | 1986-06-13 | 1991-08-20 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
LU86548A1 (en) * | 1986-08-07 | 1988-03-02 | Oreal | COMPOSITION IN THE FORM OF GEL FOR INDUCING AND STIMULATING HAIR GROWTH AND REDUCING THEIR FALL BASED ON PIPERIDINO-PYRIMIDINE DERIVATIVES |
AU7875487A (en) * | 1986-08-08 | 1988-02-24 | Upjohn Company, The | Methods, compositions and solutions for treating alopecia |
WO1988001863A1 (en) | 1986-09-12 | 1988-03-24 | The Upjohn Company | Foams for delivery of minoxidil |
JPS63150211A (en) | 1986-12-15 | 1988-06-22 | Taisho Pharmaceut Co Ltd | External drug compounded with minoxidil |
US5389677B1 (en) | 1986-12-23 | 1997-07-15 | Tristrata Inc | Method of treating wrinkles using glycalic acid |
AU618517B2 (en) | 1986-12-23 | 1992-01-02 | Eugene J. Van Scott | Additives enhancing topical actions of therapeutic agents |
US4882182A (en) | 1987-01-08 | 1989-11-21 | Soltec Research Pty. Ltd. | Aerosol product |
US4828837A (en) * | 1987-03-30 | 1989-05-09 | Liposome Technology, Inc. | Non-crystalline minoxidil composition, its production and application |
US5030442A (en) * | 1987-03-30 | 1991-07-09 | Liposome Technology, Inc. | Non-crystalline minoxidil composition |
JP2810041B2 (en) | 1987-09-09 | 1998-10-15 | 株式会社資生堂 | Hair restorer for scalp and hair |
JP2810040B2 (en) * | 1987-09-09 | 1998-10-15 | 株式会社資生堂 | Hair restorer for scalp and hair |
JPH0745387B2 (en) | 1987-09-09 | 1995-05-17 | 株式会社資生堂 | Hair growth and hair growth promoter |
KR910010018B1 (en) * | 1987-10-02 | 1991-12-10 | 가부시기가이샤 시세이도 | Hair tonic |
US4866067A (en) * | 1987-12-07 | 1989-09-12 | Ricerche De Schiena s.n.c del Dr. Michele Giuseppe Di Schiena & C. | 6-piperidino-2,4-diaminopyrimidine-3-oxide salt of 3-carboxypyridine n-oxide and topical, related compositions |
US4888354A (en) | 1987-12-21 | 1989-12-19 | Theratech, Inc. | Skin penetration enhancement using free base and acid addition salt combinations of active agents |
EP0417075B1 (en) | 1988-02-18 | 1993-06-09 | The Upjohn Company | Minoxidil gel |
US5225189A (en) * | 1988-02-18 | 1993-07-06 | The Upjohn Company | Minoxidil gel |
AU619256B2 (en) | 1988-03-03 | 1992-01-23 | Connetics Australia Pty Ltd | Acne treatment |
LU87249A1 (en) * | 1988-06-17 | 1990-02-28 | Oreal | COMPOSITION FOR INDUCING AND STIMULATING HAIR GROWTH AND / OR BRAKING HAIR LOSS, BASED ON AN AMPHOTERIC SURFACTANT AND A PYRIMIDINE DERIVATIVE |
US4938953A (en) * | 1988-08-09 | 1990-07-03 | The Upjohn Company | Self-preserving conditioning shampoo formulation |
US5104646A (en) * | 1989-08-07 | 1992-04-14 | The Procter & Gamble Company | Vehicle systems for use in cosmetic compositions |
WO1992002225A1 (en) | 1990-08-10 | 1992-02-20 | The Upjohn Company | STIMULATION OF HAIR GROWTH WITH POTASSIUM CHANNEL OPENERS AND 5α-REDUCTASE INHIBITORS |
US5935554A (en) | 1990-09-03 | 1999-08-10 | Soltec Research Pty. Ltd. | Concentrated aerosol space spray that is not an emulsion |
EP0591195A1 (en) | 1990-09-03 | 1994-04-13 | Soltec Research Pty. Ltd. | A concentrated aerosol space spray |
SK100593A3 (en) * | 1991-03-19 | 1994-07-06 | Procter & Gamble | Hair care compositions having styling/conditioning agent and plastificator |
ZA94170B (en) | 1993-01-20 | 1995-03-15 | Soltec Res Pty Ltd | Ectoparasiticidal formulation |
JPH0748230A (en) * | 1993-07-31 | 1995-02-21 | Hideo Horiuchi | Production of hair tonic |
FR2717683B1 (en) | 1994-03-22 | 1996-06-28 | Fabre Pierre Cosmetique | Hair composition based on minoxidil. |
GB9504265D0 (en) | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
US5783202A (en) | 1995-03-14 | 1998-07-21 | Soltec Research Pty. Ltd. | Pediculicidal mousse composition for killing head lice |
FR2736824B1 (en) * | 1995-07-18 | 1997-10-10 | Fabre Pierre Dermo Cosmetique | MINOXIDIL HAIR COMPOSITION WITH LOW FAT SOLVENT CONTENT |
JPH0971513A (en) | 1995-09-07 | 1997-03-18 | Taisho Pharmaceut Co Ltd | Hair tonic |
US5834014A (en) * | 1995-10-06 | 1998-11-10 | The Regents Of The University Of Michigan | Stimulation of hair follicles |
JP4467085B2 (en) * | 1996-01-05 | 2010-05-26 | 大正製薬株式会社 | Hinokitiol-containing composition |
JPH09188629A (en) | 1996-01-06 | 1997-07-22 | Pola Chem Ind Inc | Medicine for inhibiting antibody-producing cell and composition containing the same |
US5788155A (en) | 1996-06-28 | 1998-08-04 | S. C. Johnson & Son, Inc. | Air freshener dispenser device with dual cartridge capacity |
US5838669A (en) | 1996-08-28 | 1998-11-17 | At&T Corp. | Method of synchronizing satellite switched CDMA communication system |
JP3061575B2 (en) | 1996-10-17 | 2000-07-10 | 日立建機株式会社 | Drilling rig |
AUPO379596A0 (en) | 1996-11-22 | 1996-12-19 | Soltec Research Pty Ltd | Percutaneous delivery system |
JPH10158782A (en) | 1996-12-05 | 1998-06-16 | Nkk Corp | Steel sheet for shadow mask excellent in pierceability and press formability at the time of photo etching and its production |
JPH10265343A (en) | 1997-01-23 | 1998-10-06 | Taisho Pharmaceut Co Ltd | Sustained release hair growing agent |
KR20000070370A (en) | 1997-01-23 | 2000-11-25 | 우에하라 아끼라 | Persistent Hair Tonic |
JPH10279437A (en) * | 1997-03-31 | 1998-10-20 | Shiseido Co Ltd | Hair cosmetic |
AUPO688997A0 (en) | 1997-05-20 | 1997-06-12 | Soltec Research Pty Ltd | Sunscreen composition |
AUPO983897A0 (en) | 1997-10-17 | 1997-11-06 | Soltec Research Pty Ltd | Topical antifungal composition |
US6231875B1 (en) | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
JPH11302131A (en) * | 1998-04-15 | 1999-11-02 | Shiseido Co Ltd | Cosmetic for scalp and hair |
AUPP310798A0 (en) | 1998-04-22 | 1998-05-14 | Soltec Research Pty Ltd | Vehicle system for a composition comprising a piperidinopyrimidine derivative |
JPH11349451A (en) | 1998-06-08 | 1999-12-21 | Taisho Pharmaceut Co Ltd | Hair grower |
US6284234B1 (en) | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
AUPP583198A0 (en) | 1998-09-11 | 1998-10-01 | Soltec Research Pty Ltd | Mousse composition |
US6383471B1 (en) | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
AUPQ002999A0 (en) | 1999-04-29 | 1999-05-20 | Soltec Research Pty Ltd | Non-aqueous shampoo composition |
US20030157046A1 (en) * | 2000-04-07 | 2003-08-21 | Koji Imamura | Minoxidil-containing preparations |
NZ521830A (en) | 2000-04-07 | 2004-07-30 | Taisho Pharmaceutical Co Ltd | Hair growth stimulant compositions |
JP4780429B2 (en) | 2000-04-07 | 2011-09-28 | 大正製薬株式会社 | Minoxidil-containing preparation |
-
1998
- 1998-04-22 AU AUPP3107A patent/AUPP310798A0/en not_active Abandoned
-
1999
- 1999-04-20 ES ES99914373T patent/ES2268856T3/en not_active Expired - Lifetime
- 1999-04-20 EP EP99914373A patent/EP1073439B1/en not_active Expired - Lifetime
- 1999-04-20 AT AT99914373T patent/ATE331517T1/en active
- 1999-04-20 DK DK06012033.4T patent/DK1695708T3/en active
- 1999-04-20 BR BRPI9909796-6B1A patent/BR9909796B1/en not_active IP Right Cessation
- 1999-04-20 ES ES06012033.4T patent/ES2665271T3/en not_active Expired - Lifetime
- 1999-04-20 DE DE69932158T patent/DE69932158T2/en not_active Expired - Lifetime
- 1999-04-20 EP EP06012033.4A patent/EP1695708B1/en not_active Expired - Lifetime
- 1999-04-20 JP JP2000544327A patent/JP3710380B2/en not_active Expired - Lifetime
- 1999-04-20 DK DK99914373T patent/DK1073439T3/en active
- 1999-04-20 PT PT60120334T patent/PT1695708T/en unknown
- 1999-04-20 WO PCT/AU1999/000294 patent/WO1999053923A1/en active IP Right Grant
- 1999-04-20 CA CA002328950A patent/CA2328950C/en not_active Expired - Lifetime
- 1999-04-20 PT PT99914373T patent/PT1073439E/en unknown
-
2002
- 2002-04-16 US US10/124,197 patent/US6946120B2/en not_active Expired - Lifetime
-
2003
- 2003-06-24 JP JP2003178898A patent/JP4338455B2/en not_active Expired - Lifetime
-
2004
- 2004-09-10 US US10/949,116 patent/US20050037060A1/en not_active Abandoned
-
2007
- 2007-03-01 JP JP2007050885A patent/JP2007137899A/en active Pending
-
2018
- 2018-05-18 CY CY20181100524T patent/CY1120513T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2665271T3 (en) | 2018-04-25 |
CY1120513T1 (en) | 2019-07-10 |
JP4338455B2 (en) | 2009-10-07 |
JP3710380B2 (en) | 2005-10-26 |
ES2268856T3 (en) | 2007-03-16 |
US6946120B2 (en) | 2005-09-20 |
EP1695708A3 (en) | 2012-07-18 |
DK1073439T3 (en) | 2006-10-23 |
EP1695708B1 (en) | 2018-02-28 |
US20050037060A1 (en) | 2005-02-17 |
JP2002512192A (en) | 2002-04-23 |
CA2328950C (en) | 2008-07-29 |
DE69932158D1 (en) | 2006-08-10 |
ATE331517T1 (en) | 2006-07-15 |
AUPP310798A0 (en) | 1998-05-14 |
DK1695708T3 (en) | 2018-04-23 |
EP1073439B1 (en) | 2006-06-28 |
PT1073439E (en) | 2006-11-30 |
BR9909796A (en) | 2000-12-26 |
US20020172649A1 (en) | 2002-11-21 |
JP2004059587A (en) | 2004-02-26 |
WO1999053923A1 (en) | 1999-10-28 |
EP1073439A4 (en) | 2003-07-02 |
PT1695708T (en) | 2018-05-18 |
EP1695708A2 (en) | 2006-08-30 |
BR9909796B1 (en) | 2013-10-29 |
DE69932158T2 (en) | 2007-05-10 |
JP2007137899A (en) | 2007-06-07 |
EP1073439A1 (en) | 2001-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2328950A1 (en) | Piperidinopyrimidine derivatives for topical application | |
US4912124A (en) | Antifungal dermatological solution | |
CA2333869A1 (en) | Mousse composition | |
CA2143864A1 (en) | Morphinan derivatives and pharmaceutical use thereof | |
CA2389167A1 (en) | Pharmaceutical formulations of resveratrol and methods of use thereof | |
CA2301017A1 (en) | Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds | |
AU3900300A (en) | Improved aqueous solubility pharmaceutical formulations | |
CA2179682A1 (en) | Pharmaceutical, orally applicable composition | |
WO2001032596A8 (en) | Phenoxy carboxylic acid compounds and compositions for delivering active agents | |
CA2382886A1 (en) | Benzamide formulation with histone deacetylase inhibitor activity | |
CA2239174A1 (en) | Novel compounds with analgesic effect | |
US10780046B2 (en) | Pharmaceutical compositions comprising silica microspheres | |
WO2002019999A3 (en) | Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant | |
CA2258841A1 (en) | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug | |
IE871335L (en) | Steroid formulations. | |
CA2354057A1 (en) | Sustained release tablet containing hydrocolloid and cellulose ether | |
IE831611L (en) | Topical anti-inflammatory compositions | |
KR970706021A (en) | A medicinal compounding agent consisting of N-substituted-o-toluidine derivatives, and a percutaneously absorbable broth agent (hereinafter, referred to as " medicinal preparations ", " medicinal preparations for oral administration " | |
ES2002140A6 (en) | Transdermally resorbable aqueous compositions of arylpropionic-acid derivatives and process for their preparation. | |
AU2002361265A1 (en) | Pharmaceutical composition for the treatment of psoriasis and other skin diseases | |
US4670254A (en) | Gel preparations for topical application of diclofenac sodium | |
CA2223918A1 (en) | Pyrrole derivatives and medicinal composition | |
CA2360300A1 (en) | A transdermal composition of an antivomiting agent and a preparation containing the same | |
CA2378834A1 (en) | Pyrazinones, compositions containing such compounds | |
CA2264693A1 (en) | Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20190423 |